Discussions

Can anybody share their thoughts on Select Sands Corp (SLSDF)?

I invested earlier in the year in a frack sand company, Select Sands Corp (SLSDF), after a favorable Gumshoe column by Myron Martin based on a Keith Schafer bulletin. Subsequently it has dropped significantly. Things happen, I know; the oil industry remains in the doldrums overall despite Mr. Trump, but, alas, I have held onto […]

Paul Mampilly True Momentum – landmark cybersecurity recommendation ticker info?

Paul Mampilly True Momentum landmark cybersecurity recommendation ticker or company information. Could anyone share the cybersecurity ticker info? This is a legitimate sector that is primed for expansion as virtually all aspects of the global economy move into the digital realm, let alone block-chain technologies that are being adopted beyond just crypto-currencies. James Altucher is […]


Kelly says:
Ok any other thoughts
SoGiAm
SoGiAm says:
$CYBR np https://www.stockgumshoe.com/reviews/profits-unlimited/greatest-medical-breakthrough-in-history-and-mampillys-1-stock-for-2018/ Search cybr Long Gummunity sharing and caring Best2ALL

THC Breathalyzer (Cannabix Technologies inc. ticker CNSX)

Hi Everybody, i think this is worth a review and can use peoples opinion and research skills! With all the legalization and taxation happening and about to happen, its only a matter of time before the tickets for impaired driving are going to hit the streets. Let me know your imput and any ideas you […]


jjamms6 says:
$BLO fp Government releases legal limits for drugged driving but can't say how much pot is too much…

23Scadoo says:
The stock symbol listed above: CNBX is for the company called Cannabics Pharmaceuticals, NOT Cannabix Technologies, Inc.…

Massengill’s Two Picks for the “BIGGEST defense boom in American history”

Kevin Massengill has recently been pushing his Defense Technology Alert by dropping some hints about his two favorite investments… including what he says is “My Top Defense Play of All Time.” So what’s the story? Well, you could subscribe to find out, I suppose, if you feel like ponying up $2,000 a year and trust […]


texasranger says:
They recommended EPGL back in May, and it is down 58% since then. Perhaps now is the time it…

Emmanuel Petrinolis says:
I always thought that was kratos co

Fool’s “Could This $4.05 Small Cap Be the Next Netflix?”

This latest ad for Motley Fool Hidden Gems caught my eye over the weekend, partly because, yes, I am bitter about not investing in Netflix (NFLX) when the Motley Fool folks were teasing it as the “next Dell” back in 2007… but I also like a challenge sometimes, and this one’s a little short on […]


notlaw says:
I hear you I took a bath on an Under Armor recommendation from them!

TCostant says:
"It's the Great Pumpkin, Charlie Brown" will be DVR'er for the kids this Thursday (10/19) on ABC. Always loved these…

Friday File: Fairfaxes, Blackbirds, Nodaks and more

When the market is doing well, holding hedges like cash and gold is going to hurt your portfolio performance when you measure against the S&P 500 or other common benchmarks. That’s the case for me right now, and has been for the recent past — though it hasn’t been enough to bring me below the […]


Travis Johnson, Stock Gumshoe says:
I browse them in spreadsheet form, usually, on the CBOE announcements -- unless I'm specifically looking at a handful of…
Could be, we'll see -- thanks for the feedback!

LJPC

Despite the negative comments about this company on this board, it continues in phase 3 trials and the FDA has allowed the compound to be utilized even as the trial progresses. So what is the real story here?

SoGiAm
SoGiAm says:
TealWood, You may find THE #BestBiotechForum on the Planet https://www.stockgumshoe.com/author/dr-kss-md-phd/ Would NOT dream of investing in #biotech w/o…

tealwood says:
Thanks for the reply. Am new to the biotech stocks arena. Since they are allowed with FDA permission…

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.